Biochemistry and Medical Genetics - University of Manitoba
Shenna’s research will investigate DNA methylation markers that reflect pathophysiological changes associated with aggressive progression and poor prognosis in patients with chronic lymphocytic leukemia (CLL). Using microarray data, bioinformatic tools, and predictive analytics, she aims to test the validity of DNA methylation measures as determinants of CLL trajectory.